Clinical trial
Acarbose and Secondary Prevention After Coronary Stenting
NCT00221156 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other · Completed
Key facts
| NCT number | NCT00221156 |
|---|---|
| Title | Acarbose and Secondary Prevention After Coronary Stenting |
| Official title | Effects of Acarbose Long-Term Therapy on Prevention of Cardiovascular Events in Abnormal Glucose Tolerance With Coronary Artery Disease (ALERT Study) |
| Lead sponsor | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other |
| Collaborators | Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan Kobe City General Hospital |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glucose Metabolism Disorders, Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Acarbose |
| Enrollment | 300 |
| Start date | May 1, 2005 |
| Completion | Apr 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 25, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: